Search

Displaying results 8441 - 8450 of 10000 in total
  1. Drug

    FF-10101-01

    go.drugbank.com/drugs/DB16050
    Investigational

    FF-10101-01 is under investigation in clinical trial NCT03194685 (Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).

  2. Drug

    Darovasertib

    go.drugbank.com/drugs/DB16059
    Investigational

    IDE-196 is under investigation in clinical trial NCT03947385 (Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions).

  3. Drug

    Bemarituzumab

    go.drugbank.com/drugs/DB16105
    Investigational

    Bemarituzumab is under investigation in clinical trial NCT03694522 (A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (Mfolfox6) in Gastric/gastroesophageal Junction Cancer (FIGHT)).

  4. Drug

    GSK-945237

    go.drugbank.com/drugs/DB15345
    Investigational

    GSK-945237 is under investigation in clinical trial NCT01039610 (A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose … and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.).

  5. Drug

    Gevokizumab

    go.drugbank.com/drugs/DB12119
    Investigational

    Gevokizumab acts as a modulator of cytokine imbalance in IL-1 mediated disease states. It has a very high binding affinity of 300fM and blocks the activation of IL-1 receptors. … Gevokizumab has been used in trials studying the treatment of Acne Vulgaris, Osteoarthritis, Behcet's Uveitis, Pyoderma Gangrenosum, and Behcet's Disease Uveitis, among others.

  6. Drug

    Fuzapladib

    go.drugbank.com/drugs/DB19478
    Experimental

    Fuzapladib is a small molecule drug. The usage of the INN stem '-pladib' in the name indicates that Fuzapladib is a phospholipase A2​ inhibitor.

  7. Drug

    Ponalrestat

    go.drugbank.com/drugs/DB19717
    Experimental

    Ponalrestat is a small molecule drug. The usage of the INN stem '-restat' in the name indicates that Ponalrestat is a aldose reductase inhibitor.

  8. Drug

    Vatinoxan

    go.drugbank.com/drugs/DB19781
    Experimental

    Vatinoxan is a small molecule drug. The usage of the INN stem '-oxan(e)' in the name indicates that Vatinoxan is a benzodioxane derivative. Vatinoxan has a monoisotopic molecular weight of 418.17 Da.

  9. Drug

    Flesinoxan

    go.drugbank.com/drugs/DB19853
    Experimental

    Flesinoxan is a small molecule drug. The usage of the INN stem '-oxan(e)' in the name indicates that Flesinoxan is a benzodioxane derivative.

  10. Drug

    Solimastat

    go.drugbank.com/drugs/DB19872
    Experimental

    Solimastat is a small molecule drug. The usage of the INN stem '-mastat' in the name indicates that Solimastat is a matrix metalloproteinase inhibitor.